SCYNEXIS (NASDAQ: SCYX), a biotechnology company focused on positively impacting the lives of patients by delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, will present at the upcoming 17th Annual Needham Healthcare Conference at the Westin New York Grand Central on Wednesday, March 28, 2018 at 3:00 p.m. ET. A live webcast of the company’s presentation will be available in the investor section of the company’s website. Approximately two hours after the event, a replay of the presentation will be available to view for two weeks following the presentation.
To view the full press release, visit http://nnw.fm/PBAd8
SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas. The company’s lead product candidate, SCY-078, is a novel IV/oral antifungal agent in Phase 2 clinical and preclinical development for the treatment of several serious and life-threatening invasive fungal infections caused by Candida and Aspergillus species. For more information, visit the company’s website at www.scynexis.com.
More from NetworkNewsBreaks
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, please visit https://www.networknewswire.com